Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled date : 2021 - 09 - 02 save search
Voyager Therapeutics to Participate in Upcoming Investor Conferences
Published: 2021-09-02 (Crawled : 22:00) - globenewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.33%
H: 0.0%
C: 0.0%
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -7.5%
conference therapeutics
Fate Therapeutics to Present at Upcoming Investor Conferences
Published: 2021-09-02 (Crawled : 20:00) - globenewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.33%
H: 0.0%
C: 0.0%
FATE | News | $4.3 -5.29% -5.58% 2M
|
Health Technology
|
| O: -0.25%
H: 0.56%
C: -3.09%
conference therapeutics
Larimar Therapeutics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
Published: 2021-09-02 (Crawled : 20:00) - globenewswire.com
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.33%
H: 0.0%
C: 0.0%
LRMR | $6.46 0.0% 220K
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: -1.66%
conference
Civetta Therapeutics Announces the Appointment of Christopher D. Roberts, Ph.D., as CEO
Published: 2021-09-02 (Crawled : 18:00) - biospace.com/
SYRS | $5.055 -1.65% -1.68% 90K
|
Health Technology
|
| O: -1.6%
H: 6.22%
C: 6.22%
ceo
P-PSMA-101 is a High-Tscm Autologous CAR-T Targeting PSMA Producing Exceptionally Deep and Durable Responses in Castration-Resistant Metastatic Prostate Cancer (mCRPC)
Published: 2021-09-02 (Crawled : 16:00) - poseida.com
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: -4.98%
prostate cancer car-t cancer
mRNA Emerges as the Newest & Most Potent Technology in Medicine. Market to Witness Robust Growth Far Beyond the COVID-19 Pandemic
Published: 2021-09-02 (Crawled : 16:00) - prnewswire.com
TBIO | $0.311 -3.86% -4.02% 130K
|
Health Technology
|
| O: 0.05%
H: 0.69%
C: 0.29%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 0.68%
H: 0.78%
C: 0.49%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 0.82%
H: 2.46%
C: 1.15%
covid growth technology merge
Sorrento Announces Enrollment of First Subject in Brazil Phase 2 Study of COVI-MSC for Treatment of COVID-19 Associated Acute Respiratory Distress in ICU Patients
Published: 2021-09-02 (Crawled : 16:00) - globenewswire.com
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: 0.22%
H: 1.42%
C: -0.11%
covid treatment phase 2 brazil respiratory enroll
MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes
Published: 2021-09-02 (Crawled : 14:15) - biospace.com/
MNMD | $8.45 -4.74% -4.97% 830K
|
n/a
|
| O: 0.0%
H: 3.14%
C: 2.79%
BTAI | News | $2.7 -9.09% -10.0% 880K
|
Health Technology
|
| O: 0.27%
H: 2.58%
C: 1.75%
patent application
Global Roundup: VectivBio Acquires Comet Therapeutics to Expand Rare Disease Pipeline
Published: 2021-09-02 (Crawled : 14:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.48%
H: 3.28%
C: -3.28%
IMMP | $2.59 3.19% 3.09% 1.4M
|
Health Technology
|
| O: -0.49%
H: 4.69%
C: 3.95%
ACIU | $2.33 -2.1% -2.15% 320K
|
Health Technology
|
| O: 0.14%
H: 0.82%
C: -2.33%
disease rare
Scopus BioPharma Launches Duet Therapeutics
Published: 2021-09-02 (Crawled : 14:00) - biospace.com/
SCPS | $0.1682
|
|
| O: 15.07%
H: 25.76%
C: 4.94%
biopharma therapeutics
Global Roundup: VectivBio Acquires Comet Therapeutics to Expand Rare Disease ...
Published: 2021-09-02 (Crawled : 14:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.48%
H: 3.28%
C: -3.28%
IMMP | $2.59 3.19% 3.09% 1.4M
|
Health Technology
|
| O: -0.49%
H: 4.69%
C: 3.95%
ACIU | $2.33 -2.1% -2.15% 320K
|
Health Technology
|
| O: 0.14%
H: 0.82%
C: -2.33%
disease therapeutics rare
TCR² Therapeutics Receives FDA Orphan Drug Designation for Gavo-cel for the Treatment of Cholangiocarcinoma
Published: 2021-09-02 (Crawled : 14:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: 2.17%
H: 1.28%
C: -0.78%
treatment fda drug cel designation
Better For You Wellness Appoints Montel Williams, Leslie Bumgarner, Joseph Watson, David Deming, and Dr. Nicola Finley, MD to its Board of Directors
Published: 2021-09-02 (Crawled : 14:00) - globenewswire.com
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: 0.22%
H: 1.42%
C: -0.11%
HSDT | $4.82 -3.21% -3.32% 17K
|
Health Technology
|
| O: -0.11%
H: 5.11%
C: 4.68%
Atossa Therapeutics Receives Approval from the Swedish Ethics Review Authority to Initiate a Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast Density in Sweden
Published: 2021-09-02 (Crawled : 14:00) - globenewswire.com
ATOS | $1.505 1.01% 1.0% 1.9M
|
Health Technology
|
| O: 0.27%
H: 14.33%
C: 0.8%
phase 2 approval authorized
Developing piggyBac Systems “Off-the-Shelf” CAR-T Cells for Bone Marrow Transplant Conditioning
Published: 2021-09-02 (Crawled : 13:00) - poseida.com
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: -4.98%
bone car-t t-cell
Capricor Therapeutics to Present Final Data from HOPE-2 Trial with CAP-1002 in Duchenne Muscular Dystrophy at World Muscle Society 2021
Published: 2021-09-02 (Crawled : 13:00) - globenewswire.com
CAPR | $5.04 4.56% 4.37% 910K
|
Health Technology
|
| O: 2.6%
H: 4.85%
C: 2.95%
trial cap-1002 duchenne
Autolus Therapeutics to participate in upcoming virtual investor conferences
Published: 2021-09-02 (Crawled : 12:15) - biospace.com/
AUTL | $4.23 -5.58% -5.91% 2.7M
|
Health Technology
|
| O: 1.82%
H: 3.71%
C: 1.24%
conference therapeutics
Seelos Therapeutics Announces Appointment of Margaret Dalesandro to the Board of Directors
Published: 2021-09-02 (Crawled : 12:00) - prnewswire.com
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.07%
H: 0.83%
C: 0.7%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.0%
H: 0.9%
C: 0.84%
SEEL | $0.2971 -9.17% -10.1% 600K
|
Health Technology
|
| O: 1.78%
H: 1.66%
C: -3.11%
ONCS | $0.2772 25.59% 52M
|
Health Services
|
| O: -0.85%
H: 2.16%
C: 0.0%
Plus Therapeutics Announces Commercial Manufacturing Supply Agreement for Its Lead Investigational Drug
Published: 2021-09-02 (Crawled : 12:00) - biospace.com/
PSTV | News | $1.55 -4.91% -5.16% 8.4K
|
Health Technology
|
| O: 18.42%
H: 2.22%
C: -8.89%
drug commercialization
Repare Therapeutics to Participate at the 19th Annual Morgan Stanley Virtual Global Healthcare Conference
Published: 2021-09-02 (Crawled : 12:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 0.67%
H: 0.48%
C: -0.17%
RPTX 4 | $3.3 -1.79% -1.82% 73K
|
Health Technology
|
| O: 0.88%
H: 2.13%
C: 0.88%
conference
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.